Author

Andreas Wirsching

FAU Erlangen-Nurnberg;ORCID 0009-0002-6934-981XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Aline BozeciD· 1 shared Andreas MackenseniD· 1 shared Cees van KooteniD· 1 shared Eline ArendsiD· 1 shared Fabian MulleriD· 1 shared Georg SchettiD· 1 shared Laura S van DamiD· 1 shared Mahesh PanditiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Aline BozecORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

CD19-CAR T-cell therapy resets the EBV+ autoreactive B cell repertoire in autoimmune disease

Ya'el Courtney, Mahesh Pandit, Laura S van Dam, Shady Younis, Sajede Rasouli, Mengrui Zhang, Yashaar Chaichian, Shima Parsafar, Tobias V Lanz, Eline Arends, Cees van Kooten, Y. K. Onno Teng, Melanie Hagen, Andreas Wirsching, Fabian Muller, , William H Robinson

This study shows CD19-CAR T-cell therapy depletes EBV+ autoreactive B cells and resets their repertoire, leading to sustained remission, while rituximab does not.

bioRxiv · Nov 2, 2026 · PreprintImmunology